» Articles » PMID: 34675046

The Molecular and Cellular Mechanisms Associated with the Destruction of Terminal Bronchioles in COPD

Abstract

Rationale: Peripheral airway obstruction is a key feature of chronic obstructive pulmonary disease (COPD), but the mechanisms of airway loss are unknown. This study aims to identify the molecular and cellular mechanisms associated with peripheral airway obstruction in COPD.

Methods: Ten explanted lung specimens donated by patients with very severe COPD treated by lung transplantation and five unused donor control lungs were sampled using systematic uniform random sampling (SURS), resulting in 240 samples. These samples were further examined by micro-computed tomography (CT), quantitative histology and gene expression profiling.

Results: Micro-CT analysis showed that the loss of terminal bronchioles in COPD occurs in regions of microscopic emphysematous destruction with an average airspace size of ≥500 and <1000 µm, which we have termed a "hot spot". Based on microarray gene expression profiling, the hot spot was associated with an 11-gene signature, with upregulation of pro-inflammatory genes and downregulation of inhibitory immune checkpoint genes, indicating immune response activation. Results from both quantitative histology and the bioinformatics computational tool CIBERSORT, which predicts the percentage of immune cells in tissues from transcriptomic data, showed that the hot spot regions were associated with increased infiltration of CD4 and CD8 T-cell and B-cell lymphocytes.

Interpretation: The reduction in terminal bronchioles observed in lungs from patients with COPD occurs in a hot spot of microscopic emphysema, where there is upregulation of signalling, co-stimulatory immune checkpoint genes and genes related to the inflammasome pathway, and increased infiltration of immune cells. These could be potential targets for therapeutic interventions in COPD.

Citing Articles

Glypican-3 is a key tuner of the Hedgehog pathway in COPD.

Petit L, Saber Cherif L, Devilliers M, Hatoum S, Ancel J, Delepine G Heliyon. 2025; 11(1):e41564.

PMID: 39844999 PMC: 11751517. DOI: 10.1016/j.heliyon.2024.e41564.


Screening COPD-Related Biomarkers and Traditional Chinese Medicine Prediction Based on Bioinformatics and Machine Learning.

Cao Z, Zhao S, Hu S, Wu T, Sun F, Shi L Int J Chron Obstruct Pulmon Dis. 2024; 19:2073-2095.

PMID: 39346628 PMC: 11438478. DOI: 10.2147/COPD.S476808.


Dissecting causal relationships between immune cells, plasma metabolites, and COPD: a mediating Mendelian randomization study.

Cao Z, Wu T, Fang Y, Sun F, Ding H, Zhao L Front Immunol. 2024; 15:1406234.

PMID: 38868780 PMC: 11168115. DOI: 10.3389/fimmu.2024.1406234.


A model of dysregulated crosstalk between dendritic, natural killer, and regulatory T cells in chronic obstructive pulmonary disease.

Mengistu D, Curtis J, Freeman C Trends Immunol. 2024; 45(6):428-441.

PMID: 38763820 PMC: 11315412. DOI: 10.1016/j.it.2024.04.010.


Mucosal immune alterations at the early onset of tissue destruction in chronic obstructive pulmonary disease.

De Fays C, Geudens V, Gyselinck I, Kerckhof P, Vermaut A, Goos T Front Immunol. 2023; 14:1275845.

PMID: 37915582 PMC: 10616299. DOI: 10.3389/fimmu.2023.1275845.